CME Insider Daniel Kaye Buys $145K of Stock
CME Group insider Daniel Kaye bought 645 shares valued at $145,125 on June 25, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Daniel Kaye bought 645 shares of CME Group Inc. ($CME) at an average price of $225, worth about $145,125, on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CME is up 5.2% after 1 week, up 13.5% after 1 month and up 31.2% to date (from the $223.95 close on Jun 25, 2026).
CME
CME Group Inc.
Key Points
- Daniel Kaye purchased 645 shares of CME Group Inc. for $145,125 on June 25, 2026, indicating strong insider confidence.
- CME Group's stock closed at $221.00 on June 25, down from $276.01 previously, which is near its 52-week low of $218.31.
- Analysts maintain a mixed outlook on CME Group, with a consensus rating of 'hold' and a target mean price of $283.6 based on 15 opinions.
Get $CME trade alerts by text
We text you when insiders, Congress or big funds trade $CME. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Insider Buying and Selling at CME Group Inc.
On June 25, 2026, Daniel Kaye bought 645 shares of CME Group Inc. (CME) for $145,125, paying $225 per share. This purchase reflects his confidence in the company as part of a larger wave of insider buying on the same day, which included other notable purchases by CME insiders.
Other Insiders Join Kaye
Several other CME Group insiders also made purchases on June 25. Timothy Bitsberger acquired 645 shares valued at $145,125, and Ford Harold Eugene Jr. purchased 1,067 shares for $240,075. Additionally, Tierney Robert Jr. and Patrick Maloney each bought 645 shares at the same price of $225. This coordinated buying suggests a positive sentiment among insiders regarding the company's prospects.
Stock Performance Near 52-Week Low
CME Group's stock was trading at $221.00 on June 25, a significant drop from its previous close of $276.01. The stock has a 52-week low of $218.31 and a high of $329.16. The recent insider purchases come at a time when the stock is near its low, which may indicate a belief in a potential recovery.
Analysts Set New Price Targets
Analysts have a mixed outlook on CME Group, with a consensus rating of 'hold' and a target mean price of $283.6 based on 15 opinions. Notably, Wells Fargo maintains an 'Overweight' rating with a price target of $315, raised from $301. Morgan Stanley also has an 'Overweight' rating with a target of $337, suggesting optimism among certain firms despite the current stock price.
What CME Group Inc. Does
CME Group Inc. operates markets for trading futures and options on a wide range of products including interest rates, equity indexes, and commodities. The company plays a crucial role in the financial services industry, providing clearing services and market data to various clients, including institutional investors and governments.
What's Ahead for CME Group Inc.
CME Group's next earnings report is scheduled for October 21, 2026. As the company prepares for this announcement, the recent insider transactions and analyst ratings will be important to watch. Remember that these trades reflect positions as of June 25 and may not represent current holdings.
Related Filing Alerts
Source: Daniel Kaye's Form 4 filing on $CME (Jun 25, 2026). Find the original filing: CME Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts